PROMIS, which investigated the value of mpMRI to triage men with suspected prostatecancer based on elevated PSA, estimated based on transperineal mapping the NPV ofmpMRI for the detection of prostate cancer GS ≥ 3+4 in 76% (95% CI =69-82)(7). This evidence concerns the gene KLK3 and prostate carcinoma.